Abstract:Objective: To observe the ulinastatin on acute lung injury induced by lipopolysaccharide in mice protection and of TLR4/MyD88/NF-κB signaling pathway. Methods: 48 SPF Wistar male rats aged 12-15 weeks were randomly divided into four groups. The acute lung injury (ALI) model was established by intravenous injection of 0.5mL lipopolysaccharide (LPS) (5mg/kg) into the tail of the model group. The control group was given saline of equal volume. The dexamethasone (DXM) intervention group and ulinastatin (UTI) intervention group were given intraperitoneal injection of 1 mL dexamethasone (2 mg/kg) and 1 mL dexamethasone (1 mL) 24 hours and 10 minutes before LPS injection, respectively. UTI solution (5 mg/kg) was pretreated, while the control group and the model group were given saline of equal volume instead. The weight loss ratio and wet-dry weight ratio (W/D) of lung tissue were calculated for 10 hours. Pulmonary vascular endothelial permeability was measured by Evanslan method. Lung pathological changes were observed by hematoxylin-eosin staining (HE) and scored. The levels of TNF-alpha, IL-6 and IL-1 beta in bronchial lavage fluid (BALF) were detected by ELISA. The number of total cells and neutrophils was observed and counted under microscope. The expression of TLR4, MyD88 and NF-kappa B proteins in TLR4/MyD88/NF-kappa B signaling pathway was detected by Western blot. Results: Compared with control group, model group and DXM intervention group rats weight and UTI intervention group were obviously decreased (P<0.05), compared with model group, DXM intervention group and UTI intervention group obviously increased (P<0.05). Compared with control group, model group rats after by LPS stimulation, W/D ratio increased significantly (P<0.05); Compared with model group, DXM intervention group and UTI intervention group W/D ratio significantly decreased (P<0.05). Compared with control group, model group appeared the number of neutrophil and total cells in BALF significantly increased (P<0.05); Compared with model group, DXM group and ulinastatin group the number of neutrophil and total cells in BALF of obvious declined(P<0.05).Compared with control group, model group rats with Evans blue concentration appear obviously increased (P<0.05), compared with model group and DXM group and UTI group rats Evans blue concentration significantly decline, statistically significant difference (P<0.05). The control structure of lung tissue integrity, no congestion, the alveolar cavity was clear, interval found no edema and inflammatory cell infiltration. Compared with control group, the mo new alveolar cavity decreased significantly, interval appeared thickened, alveolar walls appeared hyperemia and edema, and found a lot of inflammatory cells infiltration, HE score significantly higher than the control group (P<0.05). And DXM group, ulinastatin group compared with model group, was close to normal lung tissue structure, inflammatory cells infiltration, DXM group and ulinastatin group HE scores significantly lower than the model group, the difference was statistically significant (P<0.05). Compared with control group, model group of IL-6 and IL-1,TNF-αlevel appear obviously increased (P<0.05); Compared with model group and DXM group and ulinastatin group rat BALF of IL-6 and IL-1, TNF-αlevel appear obvious dropped, statistically significant difference (P<0.05). Compared with control group, model group of TLR4, MyD88, NF-κB protein expression increased significantly (P<0.05); Compared with model group, TLR4, MyD88, NF-κB protein expression in DXM group and ulinastatin group decreased obviously, statistically significant difference (P<0.05). Conclusion: Ulinastatin can inhibit the activation of TLR4/MyD88/NF-kappa B signaling pathway induced by LPS, thereby alleviating inflammatory response and exerting protective effect on LPS-induced lung injury.
王兮, 母前途, 冯思嘉. 基于TLR4/MyD88/NF-κB通路探讨乌司他丁减轻脂多糖诱导的大鼠急性肺损伤的作用[J]. 河北医学, 2019, 25(8): 1299-1303.
WANG Xi, MU Qiantu, et al. Effect of Ulinastatin on Lipopolysaccharide-induced Acute Lung Injury in Rats based on TLR4/MyD88/NF-kappa B pathway. HeBei Med, 2019, 25(8): 1299-1303.
[1] Kacmarek R M, Villar J, Sulemanji D, et al. Open lung approach for the acute respiratory distress syndrome: a pilot, randomized controlled trial[J]. Critical Care Medicine, 2016, 44(1):32. [2] Cong L, Yang S, Zhang Y, et al. DFMG attenuates the activation of macrophages induced by co culture with LPC injured HUVE 12 cells via the TLR4/MyD88/NF κB signaling pathway.[J]. International Journal of Molecular Medicine, 2018, 41(5):2619. [3] Li X, Su L, Zhang X, et al. Ulinastatin downregulates TLR4 and NF-kB expression and protects mouse brains against ischemia/reperfusion injury[J]. Neurological Research, 2017, 39(4):367~373. [4] Kaya M, Ahishali B. Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase.[J]. Methods Mol Biol, 2011, 763(763):369~382. [5] 江宗奇.乌司他丁与奥曲肽联合治疗急性重症胰腺炎的疗效观察[J].中国医院用药评价与分析,2016,16(1):26~28. [6] Lin X, Barravecchia M, Kothari P, et al. β1-Na(+,)K(+)-ATPase gene therapy upregulates tight junctions to rescue lipopolysaccharide-induced acute lung injury.[J]. Gene Therapy, 2016, 23(6):489. [7] 庞伟,石蕊,王成彬.葛根素对支气管上皮细胞和嗜中性粒细胞接触共培养诱导白细胞介素-6合成的抑制作用[J].医学研究生学报,2017,30(7):725~729. [8] Pinheiro N M, Santana F P, Almeida R R, et al. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile[J]. Faseb Journal Official Publication of the Federation of American Societies for Experimental Biology, 2016, 31(1):320. [9] Li K, Yang J, Han X. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.[J]. International Immunopharmacology, 2016, 34:114~128. [10] Yao R B, Zhao Z M, Zhao L J, et al. Sinomenine inhibits the inflammatory responses of human fibroblast-like synoviocytes via the TLR4/MyD88/NF-κB signaling pathway in rheumatoid arthritis.[J]. Die Pharmazie, 2017, 72(6):355. [11] Su Q, Li L, Sun Y, et al. Effects of the TLR4/Myd88/NF-κB signaling pathway on NLRP3 inflammasome in coronary microembolization-induced myocardial Injury[J]. Cellular Physiology & Biochemistry International Journal of Experimental Cellular Physiology Biochemistry & Pharmacology, 2018, 47(4):1497.